Celcuity (CELC) Research & Development (2016 - 2025)
Celcuity (CELC) reported Research & Development of $37.6 million for Q4 2025, up 12.43% on a YoY basis from $33.5 million in Q4 2024, and up 7.78% quarter-over-quarter from $34.9 million in Q3 2025.
Celcuity (CELC) Research & Development (2016 - 2025) Analysis & Trends
Celcuity has reported Research & Development for 10 years, with the latest figure at $37.6 million in Q4 2025.
- For the quarter ending Q4 2025, Research & Development rose 12.43% year-over-year to $37.6 million; the trailing twelve-month figure through Dec 2025 stood at $109.8 million (up 5.34% YoY), and the FY2025 full-year result was $145.0 million, up 39.15% from the prior year.
- Research & Development for Q4 2025 stood at $37.6 million, up from $34.9 million in the prior quarter.
- The five-year high for Research & Development was $37.6 million in Q4 2025, with the low at $2.2 million in Q1 2021.
- Historically, Research & Development has averaged $16.8 million across 5 years, with a median of $13.4 million in 2021.
- Annual changes were most pronounced in 2021 — Research & Development jumped 640.0% — and 2025, when it plunged 77.78%.
- Celcuity's Research & Development stood at $5.5 million in 2021, then surged by 93.12% to $10.6 million in 2022, then soared by 70.51% to $18.1 million in 2023, then soared by 85.11% to $33.5 million in 2024, then increased by 12.43% to $37.6 million in 2025.
- The last three Research & Development figures came in at $37.6 million (Q4 2025), $34.9 million (Q3 2025), and $5.0 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 4.32 Mn |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | 15.66 Mn |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 626,092.00 |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | -101.30 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 1.46 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | -2.30 Mn |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 357,444.00 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 961.60 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -58.00 Mn |
| 10 | Celcuity | 4.14 Bn | 3.42 Bn | - | 37.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 37.63 Mn |
| Sep 30, 2025 | 34.92 Mn |
| Jun 30, 2025 | 5.00 Mn |
| Mar 31, 2025 | 32.23 Mn |
| Dec 31, 2024 | 33.47 Mn |
| Sep 30, 2024 | 27.59 Mn |
| Jun 30, 2024 | 22.50 Mn |
| Mar 31, 2024 | 20.65 Mn |
| Dec 31, 2023 | 18.08 Mn |
| Sep 30, 2023 | 17.49 Mn |
| Jun 30, 2023 | 13.75 Mn |
| Mar 31, 2023 | 11.28 Mn |
| Dec 31, 2022 | 10.60 Mn |
| Sep 30, 2022 | 9.62 Mn |
| Jun 30, 2022 | 8.37 Mn |
| Mar 31, 2022 | 6.70 Mn |
| Dec 31, 2021 | 5.49 Mn |
| Sep 30, 2021 | 4.96 Mn |
| Jun 30, 2021 | 13.07 Mn |
| Mar 31, 2021 | 2.24 Mn |